Condition
Crohn's Disease (CD)
Total Trials
4
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed1
Not Yet Recruiting1
Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06922331CompletedPrimary
Upadacitinib for Refractory IBD in Asian Children and Elderly: Age-Stratified Analysis
NCT06895772Active Not RecruitingPrimary
Microbial Community Characteristics in Intestinal Mucosal Tissue of Patients With CD
NCT06770140Not Yet RecruitingPrimary
Unraveling the Blood Microbiome in Postoperative Recurrence of Crohn's Disease
NCT01793831Not ApplicableRecruiting
Standardized Fecal Microbiota Transplantation for Crohn's Diseases
Showing all 4 trials